Originally published by our sister publication Infectious Disease Special Edition
By IDSE News Staff
After the FDA announced its new amendments to the emergency use authorizations for the Pfizer-BioNTech and Moderna COVID-19 bivalent mRNA vaccines, the CDC took steps to simplify its COVID-19 vaccine recommendations, including advising older and immunocompromised adults to receive a second dose of the updated bivalent vaccine.
Although there was no vote, the CDC’s Advisory Committee on